Venous thromboembolism (VTE), comprising deep venous thrombosis and pulmonary embolism, is a major contributor to morbidity and mortality in the U.S. We propose a 4-year renewal of the Longitudinal Investigation of Thromboembolism Etiology (LITE), a prospective study of VTE in the Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS) cohorts, comprising 21,680 participants followed for more than a decade. We have accomplished much in the previous two project periods, through identification of 548 VTEs and focusing mostly on non-genetic risk factors for VTE. This renewal focuses on identifying new genes for VTE through a genome-wide association study.
Our aims are to: (1) Extend VTE event follow-up in ARIC for 2 more years, which is expected to increase the number of LITE VTE events for genotyping by 150. (2) Measure genotypes for 500,000 SNPs spanning the human genome on 468 VTE cases and 936 controls among whites in LITE. (Genotypes in nearly 300 of these subjects will already be done in another study). Rank each SNP by its p-value for a test of association with VTE. (3) Investigate the replicability of the above results by testing the ability of the top 2,600 SNPs from Aim 2 (p<0.005) to significantly predict VTE with the same direction of effect in another case-control study, from the Mayo Clinic (1500 VTE cases and 1500 controls, almost all whites). (4) a. For the significant genes identified in Aim 3, investigate additional SNPs in the LITE and Mayo samples to permit haplotype-based analyses, test gene-gene interactions, and in LITE explore the ability of genotypes to modify the relationship between environmental and lifestyle measures (e.g., obesity, diet) and phenotype (i.e., gene-environment interactions).
This aim builds on our findings from previous project periods and will integrate the genetic and non-genetic risk factors for VTE. b. As an exploratory aim, examine whether the significant SNPs and haplotypes in whites are also associated with VTE in African Americans in LITE (n=182 cases and 364 controls). This study is designed to provide new information on genetic risk for VTE, with potential implications for prevention and treatment of VTE. Project Narrative This prospective epidemiologic study is identifying factors that contribute to increased risk of venous thromboembolism, i.e., blood clots in veins that may travel and block blood supply to organs. In this renewal proposal, we seek to identify novel genes that contribute to venous thromboembolism. This will have important implications for the prevention and treatment of this common and significant cardiovascular disease.
|Cushman, Mary; O'Meara, Ellen S; Heckbert, Susan R et al. (2016) Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology. Thromb Res 144:127-32|
|Vu, Khanh N; Ballantyne, Christie M; Hoogeveen, Ron C et al. (2016) Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study. PLoS One 11:e0148765|
|Yu, Bing; Li, Alexander H; Metcalf, Ginger A et al. (2016) Loss-of-function variants influence the human serum metabolome. Sci Adv 2:e1600800|
|van Leeuwen, Elisabeth M; Sabo, Aniko; Bis, Joshua C et al. (2016) Meta-analysis of 49â€…549 individuals imputed with the 1000 Genomes Project reveals an exonic damaging variant in ANGPTL4 determining fasting TG levels. J Med Genet 53:441-9|
|Rodriguez, Santiago; Gaunt, Tom R; Guo, Yiran et al. (2016) Lipids, obesity and gallbladder disease in women: insights from genetic studies using the cardiovascular gene-centric 50K SNP array. Eur J Hum Genet 24:106-12|
|Roberts, Jason D; Dewland, Thomas A; Glidden, David V et al. (2016) Impact of genetic variants on the upstream efficacy of renin-angiotensin system inhibitors for the prevention of atrial fibrillation. Am Heart J 175:9-17|
|Tin, A; Balakrishnan, P; Beaty, T H et al. (2016) GCKR and PPP1R3B identified as genome-wide significant loci for plasma lactate: the Atherosclerosis Risk in Communities (ARIC) study. Diabet Med 33:968-75|
|Keaton, Jacob M; Hellwege, Jacklyn N; Ng, Maggie C Y et al. (2016) GENOME-WIDE INTERACTION WITH SELECTED TYPE 2 DIABETES LOCI REVEALS NOVEL LOCI FOR TYPE 2 DIABETES IN AFRICAN AMERICANS. Pac Symp Biocomput 22:242-253|
|Liu, Ching-Ti; Raghavan, Sridharan; Maruthur, Nisa et al. (2016) Trans-ethnic Meta-analysis and Functional Annotation Illuminates theÂ Genetic Architecture of Fasting Glucose and Insulin. Am J Hum Genet 99:56-75|
|Begum, Ferdouse; Ruczinski, Ingo; Li, Shengchao et al. (2016) Identifying a Deletion Affecting Total Lung Capacity Among Subjects in the COPDGene Study Cohort. Genet Epidemiol 40:81-8|
Showing the most recent 10 out of 315 publications